NCT00836849View on ClinicalTrials.gov

Sertraline Hydrochloride 100 mg Tablets, Fasting

PHASE1CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

March 31, 2002

Primary Completion Date

April 30, 2002

Study Completion Date

April 30, 2002

Conditions
Healthy
Interventions
DRUG

Zoloft® 100 mg Tablets

1 x 100 mg, single-dose fed

DRUG

Sertraline hydrochloride 100 mg Tablets

1 x 100 mg, single-dose fed

Trial Locations (1)

GIV2K8

Anapharm Inc., Sainte-Foy

All Listed Sponsors
lead

Teva Pharmaceuticals USA

INDUSTRY

NCT00836849 - Sertraline Hydrochloride 100 mg Tablets, Fasting | Biotech Hunter | Biotech Hunter